MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-29-2023
Chembio Diagnostics ROCE Ratio 2011-2026 | CEMI
Annual ROCE Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -132.81 | -90.63 | -41.78 | -25.58 | -22.23 | -47.95 | -44.1 | -20.12 | -7.86 | 4.98 | 10.4 | 8.61 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.4 | -132.81 | -34.09 |
Quarterly ROCE Ratio Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -94.35 | -106.1 | -53.84 | -109.04 | -83.51 | -101.18 | -107.1 | -78.06 | -59.73 | -74.74 | -72.08 | -59.65 | -41.62 | -48.61 | -40.59 | -32.12 | -14.22 | -18.72 | -16.22 | -27.64 | -33.63 | -46.12 | -54.1 | -51.33 | -29.11 | -32.39 | -23.18 | -14.37 | -13.32 | -14.65 | -12.7 | -8.8 | -4.45 | 0.87 | 7.53 | 6.82 | 5.85 | 2.36 | -6.46 | -0.89 | 5.38 | 9.22 | 16.55 | 14.44 | 4.3 | 3.84 | 1.58 | -1.11 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.55 | -109.04 | -31.4 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
25.0 | $ 121.52 | 2.82 % | $ 36.9 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 21.61 | -3.96 % | $ 237 M |  China |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 21.8 | -2.77 % | $ 1.16 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.56 | 6.51 % | $ 2.08 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 25.2 | 2.59 % | $ 700 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 185.09 | 4.61 % | $ 9.17 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 196.98 | 1.65 % | $ 140 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 517.52 | 0.36 % | $ 14.9 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 133.54 | 0.62 % | $ 21.2 B | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 5.17 | 3.4 % | $ 479 M | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.38 | 1.55 % | $ 495 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.42 | 3.19 % | $ 1.08 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.6 | 3.84 % | $ 2.08 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 90.86 | 6.02 % | $ 11.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B |  Niderland |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 29.93 | 4.54 % | $ 20 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.84 | 0.35 % | $ 92.2 K | USA |
 |
Precipio
PRPO
|
-8.25 | $ 28.55 | -1.55 % | $ 45.8 M | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.18 | -0.91 % | $ 5.01 M | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 119.34 | 3.25 % | $ 9.84 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 271.53 | 1.94 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
-171.24 | $ 123.97 | -1.02 % | $ 5.8 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.87 | 1.48 % | $ 287 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.63 | 0.1 % | $ 2.67 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 84.9 | 1.17 % | $ 5.73 B | USA |
 |
Neuronetics
STIM
|
-140.48 | $ 1.47 | 4.64 % | $ 96.9 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 193.97 | 1.31 % | $ 21.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 5.17 | - | $ 4.07 M | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 18.09 | 2.64 % | $ 405 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |